All In Biotech

Drug Trial Radar · NCT05480579

A Study of IBI311 in Healthy Volunteers

A Dose Escalation Phase I Clinical Study to Evaluate the Tolerability and Safety of a Single Intravenous Injection IBI311 in Healthy Volunteers

Last checked: Nov 19, 2026Latest source record: Oct 11, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

28

Actual

Start

Aug 10, 2022

Primary completion

Nov 23, 2022

Study completion Jan 19, 2023

Sponsor

Sponsor type
Industry
First posted
Jul 29, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

It is designed for Multi-center, double-masked, randomized, placebo- control study with dose escalation phase I trial to evaluate the safety, tolerability, PK and immunogenicity profiles of a single intravenous injection of IBI311 in healthy volunteers.

Conditions

  • Healthy

Interventions

  • placeboBiological

    Dose4 placebo of single IV injection

  • IBI311Biological

    Dose2 IBI311 of single IV injection

  • IBI311Biological

    Dose4 IBI311 of single IV injection

  • placeboBiological

    Dose3 placebo of single IV injection

  • placeboBiological

    Dose1 placebo of single IV injection

  • IBI311Biological

    Dose1 IBI311 of single IV injection

  • IBI311Biological

    Dose 3 IBI311 of single IV injection

  • placeboBiological

    Dose2 placebo of single IV injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence, relatedness and severity of all adverse events, treatment emergent adverse events and serious adverse eventsTime frame: Up to 16 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

    Shanghai, Shanghai Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.